INTRODUCTION
India being a tropical country, it is thought that vitamin D deficiency would not be common. Despite abundant sunshine, vitamin D deficiency has been recognized to be highly prevalent in India as reported from studies done in Delhi (28.3°N), 1 Lucknow (26.8°N) 2 and Tirupathi (13.4°N). 1 The high prevalence of vitamin D insufficiency during pregnancy is increasingly recognized, especially in dark women, following customs like veil, in women living in northern latitudes and during winter season. 1, 3, 4 Maternal effects of hypovitaminosis D have been reported to cause calcium malabsorption, bone loss, poor weight gain, subclinical myopathy, 5 increased preeclampsia (PE), 6 increased gestational diabetes mellitus (GDM), 7 increased cesarean sections. 8 In the newborn, hypovitaminosis D has been reported to cause neonatal tetany, 9 hyperbilirubinemia, 10 large fontanelle, enamel defects, congenital rickets, and infantile rickets. 11 There is growing evidence that hypovitaminosis D can also have long-lasting effects on health of the offspring, i.e., impaired skeletal growth and rickets. 5, 11 In a community-based study of 901 mother and offspring pairs, researchers found that maternal vitamin D deficiency (serum 25-hydroxyvitamin D [25(OH)D] < 50 nmol/L) at 18 weeks pregnancy was associated with impaired lung development at age 6 in offspring, neurocognitive difficulties at age 10, increased risk of eating disorders in adolescence, and lower peak bone mass at 20 years of age. 12 Very few Indian studies have been done regarding vitamin D status during pregnancy, so it was considered worthwhile to study vitamin D status in pregnancy, its fetomaternal effects, and its correlation with cord blood levels.
AIMS AND OBJECTIVES
To estimate total serum vitamin D, i.e. 25(OH)D 2 + 25(OH) D 3 levels in pregnancy and find out its association with fetomaternal outcome and cord blood 25(OH)D levels.
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MATERIAlS AND METHODS
This study was a prospective observational study conducted in the Department of Obstetrics and Gynecology at a tertiary hospital in Delhi, India, from March 2012 to February 2013. Approval from Institutional Ethical Committee was obtained. After informed written consent, 70 pregnant women with singleton pregnancy attending antenatal clinic in third trimester were enrolled in consecutive order and followed up till 48 hours of delivery. Pregnant women having known liver disorders, kidney disorders, history of antitubercular and antiepileptic drugs, pregestational diabetes, and chronic hypertension were excluded from the study. Women taking vitamin D supplements were excluded from the study. All women were counseled for diet with good nutritive value as per routine for all pregnant women, including leafy vegetables, milk, curd, eggs, cheese, pulses, fruits. As a routine for antenatal women, they were advised to take ferrous sulfate 100 mg and calcium 500 mg tablets twice a day. Demographic data, detailed history, physical examination, and obstetric examination were recorded.
All women were subjected to routine antenatal investigations and other relevant investigations if required. Screening for GDM was done by estimating blood glucose levels 2 hours after 75 gm glucose intake in all women at 24 to 28 weeks. A value ≥140 mg% was taken as diagnosis of GDM. 13 Any complication occurring during antenatal period was recorded. Serum calcium and serum vitamin D were estimated during admission to labor ward. Vitamin D was estimated by chemiluminescence method. All the women were followed up till delivery and 48 hours postpartum. After delivery, cord was cut and blood sample was collected from the maternal end of cord for estimation of 25(OH)D. Fetal outcome parameters like birth weight and crown heel length were recorded. Head circumference and fontanelle size were measured after 24 hours of birth. Baby was observed for development of any neonatal jaundice, tetany, or seizure. All the observations were recorded on a predesigned proforma and analyzed.
ESTIMATION OF VITAMIN D
Vitamin D was estimated in all women using CLIA Cobas e 411 (Roche) in the Pathology Department. The most reliable marker of vitamin D status is its metabolite, 25(OH) D, which has a half-life of 3 weeks, is biologically inactive with levels approximately 1,000 times greater than its active metabolite, i.e., 1,25(OH)D.
The assay employs a vitamin D binding protein (VDBP) as a capture protein in the assay which binds to 25(OH)D. Addition of microparticles and hydroxy vitamin D labeled with biotin causes the free sites of VDBP to become occupied. The microparticles are magnetically captured on an electrode which induces chemiluminescent emission measured by a photomultiplier. Vitamin D insufficiency was considered as levels <20 ng/mL in our study.
Statistical Analysis
Categorical variables were expressed as number of patients, percentages and compared across the groups using Pearson's chi-square test for independence of attributes. Continuous variables were expressed as mean ± standard deviation and compared across the groups using unpaired t-test and analysis of variance test where applicable. Statistical Package for the Social Sciences software version 16 was used for analysis. An alpha level of 0.05 was considered significant.
RESUlTS
Out of 70 subjects recruited fulfilling inclusion criteria, 54 subjects could be followed up for delivery and up to 48 hours postpartum.
The mean age of women in our study was 23.89 ± 3.2 years. Most of the women belonged to the age group 21 to 25 years. The mean body mass index (BMI) of women was 24.32 ± 4.09. Majority of women were Hindu by religion. Except for BMI the demographic distribution of women in terms of age, religion, and season was comparable in relation to vitamin D (Table 1) .
The baseline investigations, i.e., mean hemoglobin, total leukocyte count (TLC), platelet counts, and serum calcium, were in the normal reference range. Mean vitamin D level was found to be low (6.81 ± 7.38 ng/dL) in our study (Table 2) .
Basic parameters in terms of BMI, TLC, and serum calcium were found to be statistically significant in various subgroups of vitamin D levels. Preeclampsia and GDM were also found to be significantly more (p-values 0.023 and 0.039 respectively) in women with lower vitamin D level subgroup (Table 3) .
Fetomaternal outcome and mean vitamin D was also evaluated. It was seen that mean vitamin D was significantly higher (p-value 0.001) in women who were normotensive and normoglycemic compared with those having PE and GDM. Vitamin D was found to be comparable in terms of onset of labor i.e. spontaneous or induced labor and mode of delivery i.e. vaginal or cesarean delivery. Birth weight and neonatal biometry also did not have any significant difference in terms of mean vitamin D levels. Vitamin D was significantly higher (p-value 0.001) in women whose babies did not have jaundice and tetany than those having neonatal jaundice and tetany (Table 4) .
A strong positive correlation was found between maternal serum vitamin D and cord blood vitamin D (p-value 0.001, r-value 0.9; Table 5 and Graph 1).
DISCUSSION
The mean age in our study was 23.89 ± 3.2 years ( India. 16 Dasgupta et al 17 showed 56% of prevalence from northeastern part of India. A predominant nonvegetarian food habit might be the cause for lower percentage of hypovitaminosis D. Despite abundant sunshine in our country, the high prevalence of vitamin D deficiency might be due to darker skin with melanin preventing the entry of ultraviolet (UV) rays in the skin, people remaining indoors mainly, use of sunscreens, malabsorption, less exposure to sunshine, a vegetarian diet, less intake of calcium in the form of milk and other dairy products being expensive, nonfortified foods, and milk. Vitamin D insufficiency was seen in 9% (serum vitamin D 10-20 ng/mL) of women and 19% were found to be deficient (serum vitamin D 5-<10 ng/mL). Severe deficiency (serum vitamin D <5 ng/mL) was seen in 65% women. Only 7% women had optimal levels of vitamin D in our study.
In our study, the mean maternal serum 25(OH)D level was 6.81 ± 7.38 ng/mL (Table 2) . A value of 14 ± 9.5 ng/ Vitamin D also appears to play a role in reducing inflammation. Those with adequate levels of vitamin D in their blood were less likely to develop inflammation. An inverse relation between 25(OH)D below its median and C-reactive protein (CRP) was found to be significant (geometric mean CRP change 0.11 mg/dL for each 10 ng/mL change in 25(OH)D). 21 A significant difference in leukocyte count was observed in vitamin D-deficient women in our study (p-value 0.001; Table 2 ). Excess 1,25(OH)2D is produced in an effort to upregulate the vitamin D receptor (VDR) to express antimicrobial peptides, such as cathelicidin and beta defensins which attack pathogens, and 25(OH)D is rapidly metabolized in the process, resulting in a low serum level. 22 Several studies highlighted that maternal vitamin D deficiency was an independent risk factor for PE as reported by Bodnar et al. 6 The active form of vitamin D, 1,25(OH)2D 3 , has been shown to regulate the transcription and function of genes associated with placental invasion, normal implantation, and angiogenesis 23 supported by the known stimulatory effects of calcitriol on the expression of vascular endothelial growth factor in vascular smooth muscle cells through vitamin D response elements in the vascular endothelial growth factor promoter. 24 It is also believed to be important in directing immune responses by dendritic cells and macrophages at the fetal/placental interface as well as immunological adaptation by the mother to reduce the risk of infection and inflammation. 23 In our study, there were significantly more (p-value 0.023) number of women who developed PE (n = 16) in the severe deficiency group. No women had PE with vitamin D sufficiency group (vitamin D >20 ng/mL; Table 3 ). The mean vitamin D levels in women who developed PE were 3.31 ± 0.99 ng/mL, which was significantly low (p-value 0.001) compared with mean vitamin D (8.43 ± 8.44 ng/mL) in women who did not develop PE (Table 4) . Extrapolating this observation, it can be said that supplementing vitamin D can reduce risk of PE in pregnant women and can help in reducing PE-related fetomaternal morbidity and mortality.
Vitamin D enhances expression of insulin gene, resulting in high insulin synthesis. 25 It also influences insulin secretion by regulating intracellular calcium levels 26 in insulin-sensitive tissues, such as muscle and adipose tissues. Vitamin D also improves insulin resistance by upregulating the insulin receptors. 27 As hypovitaminosis D by promoting inflammatory response induces insulin resistance, vitamin D by its modulating effect on the immune system 28 enhances insulin response.
The difference in mean vitamin D level in GDM and non-GDM group (3.69 ± 1.67 and 8.80 ± 8.83 ng/mL respectively) was found to be statistically significant (p-value < 0.001) in our study (Table 4 ). In women who developed GDM (n = 21), 85.7% (n = 18) belonged to the severe deficiency group (Table 3) . Therefore, supplementing vitamin D might reduce risk of GDM in pregnant women and its associated adverse fetomaternal outcomes. Women with cesarean deliveries had lower mean vitamin D compared with those having vaginal deliveries, though the difference was not significant in our study. Vitamin D was lower with spontaneous onset of labor compared with induction. There was no association between low vitamin D level and need of induction of labor (p-value 0.786) or mode of delivery in our study (p-value 0.326; 35 We found a strong association between severe vitamin D deficiency and neonatal jaundice (p-value <0.001; Table 3 ) similar to that reported by Mutlu et al. 10 Although bilirubin and vitamin D metabolisms are two distinct pathways and are very different, at least one part of the synthesis takes place in a common organ, the liver. Therefore, the metabolism or synthesis of one may affect the other. 10 The mean cord blood vitamin D was 6.34 ± 7.05 ng/mL. Deficiency of vitamin D (levels < 10 ng/mL) was seen in 81.5% (n = 44) of babies and 83.3% (n = 45) of mothers. There was an excellent positive correlation between maternal and cord blood vitamin D levels (p-value 0.001, r-value 0.9; Table 5 
